Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT06373107
Other study ID # 2117651-2
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date April 11, 2024
Est. completion date January 31, 2026

Study information

Verified date April 2024
Source Alvernia University
Contact Soo Yeon Sun, PhD
Phone 6107968398
Email soo.sun@alvernia.edu
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this research is to study the improvements from walking practice that is vigorous enough to keep participants' heart rate over a certain target level during their physical therapy sessions. The investigators want to know about improvements in participants' walking function and mental health after 20 interventions. The study also aims to evaluate if participants' mental health, social support, and health literacy affect their attendance at physical therapy sessions.


Description:

The purpose of this research is to study the improvements from walking practice that is vigorous enough to keep participants' heart rate over a certain target level during their physical therapy sessions. The investigators want to know about improvement in participants' walking function and mental health after 20 interventions. The study also aims to evaluate if participants' mental health, social support, and health literacy affect their attendance at physical therapy sessions. The findings from this study will help the researchers and clinicians decide how to help people with stroke better. Further, the findings will determine how depressive symptoms, health literacy, and other factors such as language and education affect attendance to therapy. About 24 subjects will take part in this research.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 24
Est. completion date January 31, 2026
Est. primary completion date October 30, 2025
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - 18 years of age or older - English or Spanish speaking - A diagnosis of stroke (intracerebral hemorrhage or acute ischemic stroke) - Referred to LVHN Outpatient Neurologic Rehab (hereafter referred to as outpatient PT) Exclusion Criteria: - Unable to follow 1-step commands - > 220 pounds (100 kg) - Height < 5'0" or > 6'4" - Unable to take a few steps with assistance - A score of = 50/56 on Berg Balance Scale (BBS) - A score of = 26/30 on Functional Gait Assessment (FGA) - Resting blood pressure >180/110 mmHg - Resting heart rate > 120 bpm - Severe cardiac disease (New York Heart Association Classification IV) - Severe spasticity (Modified Ashworth score > 3) - Unstable spine or unhealed pelvic/limb fractures - Active heterotrophic ossification impacting lower extremity range of motion - Significant lower or upper extremity contractures - Inability to achieve neutral ankle dorsiflexion with 12° of knee flexion - Pregnancy - Colostomy - Poor skin integrity - Unresolved deep vein thrombosis - Lower limb prosthesis or amputation - Leg length discrepancies > 0.5 inches for upper legs, 0.75 inches for lower legs - ROM restrictions preventing normal, reciprocal gait - Inability to stand for > 3 minutes due to pain or orthostatic hypotension - Pusher syndrome - Cortical blindness

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
High intensity gait training
Participants will practice walking that is vigorous enough to keep their heart rate over a certain level during their physical therapy sessions. During the sessions, participants will walk and step vigorously enough to keep the heart rate between 60-80% of their maximum heart rate. Maintaining this heart rate during exercise helps to improve heart health and walking, which can affect people after a stroke.

Locations

Country Name City State
United States Lehigh Valley Health Network Outpatient Neurologic Rehab Allentown Pennsylvania

Sponsors (2)

Lead Sponsor Collaborator
Alvernia University Lehigh Valley Health Network

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary 3-meter backwards walk test Measures backward gait velocity Pre-, mid- (week 5) and post-intervention (within 2 weeks after the conclusion of intervention)
Primary 6-minute walk test Measures aerobic capacity and endurance Pre-, mid- (week 5) and post-intervention (within 2 weeks after the conclusion of intervention)
Primary 10-meter walk test Measures forward gait velocity Pre-, mid- (week 5) and post-intervention (within 2 weeks after the conclusion of intervention)
Primary Surface electromyography (EMG) Electromyographical recording of 8 leg muscles () is done during forward and backward walking tests.The EMG will be recorded during 3-meter Backward Walk Test, 6-minute Walk Test, and 10-meter Walk Test in all participants Pre-, mid- (week 5) and post-intervention (within 2 weeks after the conclusion of intervention)
Primary Berg Balance Scale a 14-item objective measure that assesses static balance and fall risk in adults. Berg balance scale scoring ranges from 0 to 56, with higher scores mean a better outcome. Pre-, mid- (week 5) and post-intervention (within 2 weeks after the conclusion of intervention)
Primary Functional Gait Assessment This scale assess postural stability during walking and assesses an individual's ability to perform multiple motor tasks while walking. Scoring for each FGA item ranges from 0 for severe impairment to 3 for normal performance. The highest score possible is 30, with higher scores correlating better gait function. Pre-, mid- (week 5) and post-intervention (within 2 weeks after the conclusion of intervention)
Primary Borg Rating Scale of Perceived Exertion (RPE) RPE is used to prescribe and monitor exercise intensity and correlates well with physiological measures of exercise intensity, including heart rate. The Borg Rating Scale of Perceived Exertion will be measured in all participants at the completion of 6 Minute Walk test. It ranges from 6 to 20, where 6 means "no exertion at all" and 20 means "maximal exertion." A lower score indicates a better exercise endurance. Pre-, mid- (week 5) and post-intervention (within 2 weeks after the conclusion of intervention)
Primary Patient Health Questionnaire (PHQ-9) Depressive symptom questionnaire. As a severity measure, the PHQ-9 score can range from 0 to 27, since each of the 9 items can be scored from 0 (not at all) to 3 (nearly every day). A lower score indicates less depressive symptoms. Pre-, mid- (week 5) and post-intervention (within 2 weeks after the conclusion of intervention)
Primary Rate of patient attendance (Compliance) to physical therapy Greater than or equal to 80% attendance to physical therapy is considered compliance to physical therapy. Participant's attendance to physical therapy is tracked throughout the intervention sessions.
Primary Newest Vital Sign The NVS is a 6-question screening tool that identifies participants' risk of low or limited health literacy based on interpreting an ice cream nutrition label. It is available from Pfizer Pharmaceutical Company. The level of health literacy for each individual will be categorized based on the scores: a score of 0-1 suggests a high likelihood of limited literacy, a score of 2-3 indicates the possibility of limited literacy, and a score of 4-6 almost always indicates adequate literacy. This categorical variable will be used to determine the association with adherence to physical therapy. Pre-intervention (baseline)
Primary Multidimensional Scale of Perceived Social Support (MSPSS) The MSPSS is a 12-item self-administered scale that measures social support. It contains 12-items, rated on a 7-point Likert-type scale, ranging from 1 "very strongly disagree" to 7 "very strongly agree." The scale was divided into 3 subscales: family, friends, and significant other, with each section consisting of 4 items. The response scale ranges from 12 to 84. Higher scores indicate a greater family social support. Pre-intervention (baseline)
See also
  Status Clinical Trial Phase
Recruiting NCT04043052 - Mobile Technologies and Post-stroke Depression N/A
Recruiting NCT03869138 - Alternative Therapies for Improving Physical Function in Individuals With Stroke N/A
Completed NCT04101695 - Hemodynamic Response of Anodal Transcranial Direct Current Stimulation Over the Cerebellar Hemisphere in Healthy Subjects N/A
Completed NCT04034069 - Effects of Priming Intermittent Theta Burst Stimulation on Upper Limb Motor Recovery After Stroke: A Randomized Controlled Trial N/A
Terminated NCT03052712 - Validation and Standardization of a Battery Evaluation of the Socio-emotional Functions in Various Neurological Pathologies N/A
Completed NCT00391378 - Cerebral Lesions and Outcome After Cardiac Surgery (CLOCS) N/A
Recruiting NCT06204744 - Home-based Arm and Hand Exercise Program for Stroke: A Multisite Trial N/A
Active, not recruiting NCT06043167 - Clinimetric Application of FOUR Scale as in Treatment and Rehabilitation of Patients With Acute Cerebral Injury
Active, not recruiting NCT04535479 - Dry Needling for Spasticity in Stroke N/A
Completed NCT03985761 - Utilizing Gaming Mechanics to Optimize Telerehabilitation Adherence in Persons With Stroke N/A
Recruiting NCT00859885 - International PFO Consortium N/A
Recruiting NCT06034119 - Effects of Voluntary Adjustments During Walking in Participants Post-stroke N/A
Completed NCT03622411 - Tablet-based Aphasia Therapy in the Chronic Phase N/A
Completed NCT01662960 - Visual Feedback Therapy for Treating Individuals With Hemiparesis Following Stroke N/A
Recruiting NCT05854485 - Robot-Aided Assessment and Rehabilitation of Upper Extremity Function After Stroke N/A
Active, not recruiting NCT05520528 - Impact of Group Participation on Adults With Aphasia N/A
Completed NCT03366129 - Blood-Brain Barrier Disruption in People With White Matter Hyperintensities Who Have Had a Stroke
Completed NCT05805748 - Serious Game Therapy in Neglect Patients N/A
Completed NCT03281590 - Stroke and Cerebrovascular Diseases Registry
Recruiting NCT05993221 - Deconstructing Post Stroke Hemiparesis